A 2024 case series in Journal of Clinical Endocrinology reported that patients receiving combination therapy showed 18% greater fat mass reduction compared to GLP-1 monotherapy, with improved energy scores on validated fatigue assessments (Morrison et al., 2024)
"What's particularly encouraging is that the benefit appears to increase over time rather than fade, and that it behaves like a drug in terms of dose response," Dr Sullivan said, adding that the results give confidence that we're targeting the right biology
Disinfect the treatment area with 70% isopropyl alcohol
Kepa, S.L
These findings reinforce the view that obesity is a chronic, relapsing condition, and that ongoing treatment may be necessary to sustain the health benefits achieved with incretin-based therapies
The mechanism behind the stimulation of zoospore release by glutathione is not yet clear, but the observation that both GSH and GSSG elicit a zoospore response, whereas mucin or BME does not, implies that Bd is not merely responding to exposure to host tissue or a generalised redox change, as hypothesised in B
